Abstract: This article discusses a standardized 0–8 scoring system developed to monitor Leishmania skin lesions in the murine ear model. By integrating qualitative clinical signs with quantitative physical measurements, this method addresses the limitations of traditional diameter and volume metrics, providing a more accurate representation of disease progression from early inflammation to late-stage necrosis.
Introduction
For decades, the standard experimental model for studying Leishmania involved high-dose parasite injections into the mouse footpad. However, to more closely simulate natural transmission by sand fly bites, the research community has shifted toward low-dose intradermal injections in the mouse ear. While more biologically relevant, the ear model presents unique monitoring challenges due to its thin, complex anatomy. Traditional methods—such as measuring lesion diameter, volume, or thickness—often fail to capture the full spectrum of the disease, particularly during the early "silent phase" and the late stages of tissue destruction.
The Limitations of Conventional Metrics
Existing measurement techniques often provide a misleading picture of infection at the extremes of the timeline:
- Diameter: While precise during mid-stage infection, diameter measurements frequently miss early-stage inflammation. More critically, they often show a "plateau" in late-stage infections in susceptible mice, failing to account for the qualitative shift toward necrosis.
- Volume: Calculated using ellipsoid formulas, volume measurements are particularly prone to the "Volume Paradox." When a lesion ulcerates and tissue is lost to necrosis, the calculated volume decreases. On paper, this suggests the mouse is healing, whereas, in reality, the pathology is worsening.
- Thickness: Swelling measurements across the ear pinna using calipers have been found to be the least reliable metric, suffering from high inter-investigator variability and the inherent difficulty of measuring such a narrow structure.
The 0–8 Scoring Framework
To resolve these issues, researchers proposed a new scoring system that combines physical dimensions with clinical observations. This 0–8 scale allows for a more linear and holistic tracking of the infection:
- 0: No visible lesion.
- 0.5: Erythema (redness), capturing the earliest inflammatory response.
- 1.0: Appearance of the first palpable papule.
- 1.5–5.5: Incremental scores based on the longest lesion dimension (length) in 0.5 mm steps.
- 6.0–8.0: Advanced clinical signs, including the onset of necrosis (crusting), severe necrosis, and eventual total tissue destruction.
Key Results and Validation
The scoring method was validated using various murine models, including resistant C57BL/6 mice and susceptible BALB/c and MyD88−/− mice, across both high-dose ($10^5$) and low-dose ($10^3$) infections.
The study demonstrated that the 0–8 scale provides a more robust reflection of the clinical state than diameter alone. As shown in Figure 1, diameter measurements in low-dose infections can plateau or even decline as the disease progresses into necrotic stages. The new scoring system corrects for this by assigning higher values to tissue loss and necrosis, ensuring that the data accurately reflects the worsening pathology rather than just physical dimensions.
Discussion and Future Directions
By including scores for early redness and late-stage necrosis, the system captures the "silent phase" of infection and the severe end-stage pathology that traditional calipers ignore. This standardization allows researchers to plot data from resistant and susceptible strains on the same scale without skewing the results.
While the system introduces a minor degree of subjectivity in identifying early clinical signs (like erythema), it offers a significant improvement in accuracy for vaccine evaluation and drug screening. Future applications of this method will likely improve the comparability of results across different laboratories, providing a clearer understanding of how various treatments affect every stage of Leishmania lesion development.
Reference: Schuster, S., Hartley, M.-A., Tacchini-Cottier, F., & Ronet, C. (2014). A scoring method to standardize lesion monitoring following intra-dermal infection of Leishmania parasites in the murine ear. Frontiers in Cellular and Infection Microbiology, 4, Article 67.
Summary updated